Skip to main content
. 2011 Nov 16;97(2):589–598. doi: 10.1210/jc.2011-2561

Table 2.

Glucagon and GLP-1 concentrations according to categorization of fasting glucose and glucose tolerance status

NFG/NGT IFG/NGT NFG/IGT IFG/IGT IFG/DM Pa
Fasting active GLP-1 4.5 ± 0.5 5.7 ± 0.7 4.6 ± 0.5 5.7 ± 0.5 5.7 ± 0.9 0.30
Maximum active GLP-1 25.1 ± 4.0 20.2 ± 2.6 23.8 ± 3.0 19.6 ± 2.1 18.4 ± 2.5 0.54
Active GLP-1 AUC 1623 ± 162 1456 ± 143 1671 ± 176 1466 ± 103 1435 ± 164 0.74
Active GLP-1 AAB 1085 ± 146 774 ± 137 1117 ± 159 785 ± 82 755 ± 144 0.13
Pb 0.18 0.88 0.06 0.18
Fasting total GLP-1 48.7 ± 7.5 38.6 ± 7.5 32.5 ± 6.9 41.2 ± 4.5 37.4 ± 6.1 0.48
Max total GLP-1 84.5 ± 18.1 73.6 ± 11.7 93.7 ± 18.3 80.4 ± 10.3 91.7 ± 24.1 0.90
Total GLP-1 AUC 7324 ± 736 6980 ± 1160 7328 ± 936 7058 ± 603 8605 ± 2166 0.90
Total GLP-1 AAB 1480 ± 623 2346 ± 901 3427 ± 457 2112 ± 421 2116 ± 655 0.10
Pb 0.43 0.009 0.39 0.57
Fasting glucagon 74.6 ± 3.5 72.5 ± 3.6 71.2 ± 3.2 76.6 ± 3.3 91.5 ± 10.4 0.08
Pb 0.71 0.48 0.69 0.06
Glucagon nadir 53.2 ± 3.0 52.7 ± 3.8 55.4 ± 2.9 55.3 ± 2.4 60.5 ± 5.9 0.73

Data represent mean ± sem. AUC, Area under the curve.

a

P value calculated by ANOVA.

b

P value calculated by two-tailed t test in comparison with NFG/NGT.